Accelerate Diagnostics Investor Relations Material

Accelerate Diagnostics Inc. is an in vitro diagnostics company specializing in rapid diagnostic solutions for infectious diseases. The company develops and markets systems and tests that enable the identification of pathogens and the determination of antimicrobial susceptibility directly from patient samples. Its flagship product, the Accelerate Pheno system, provides faster diagnostic results compared to traditional methods, helping healthcare providers optimize antimicrobial therapy and improve patient outcomes. The company is headquartered in Tucson, Arizona, and its shares are listed on the NASDAQ.